| 1 |
35500753 | Estrogen treatment reduced oxalate transporting activity and enhanced migration through the involvement of SLC26A6 in lung cancer cells. | 2022 Aug |
2 |
| 2 |
34231328 | Evidence for abnormal linkage between urine oxalate and citrate excretion in human kidney stone formers. | 2021 Jul |
1 |
| 3 |
32660969 | Enteric Oxalate Secretion Mediated by Slc26a6 Defends against Hyperoxalemia in Murine Models of Chronic Kidney Disease. | 2020 Sep |
1 |
| 4 |
31042422 | miR-125a-5p: a novel regulator of SLC26A6 expression in intestinal epithelial cells. | 2019 Aug 1 |
1 |
| 5 |
30020825 | Adenosinergic signaling inhibits oxalate transport by human intestinal Caco2-BBE cells through the A2B adenosine receptor. | 2018 Nov 1 |
3 |
| 6 |
30864378 | Sex-independent expression of chloride/formate exchanger Cfex (Slc26a6) in rat pancreas, small intestine, and liver, and male-dominant expression in kidneys. | 2018 Dec 1 |
1 |
| 7 |
26812303 | In Silico Screening and Molecular Dynamic Study of Nonsynonymous Single Nucleotide Polymorphisms Associated with Kidney Stones in the SLC26A6 Gene. | 2016 Jul |
3 |
| 8 |
27681177 | N-glycosylation critically regulates function of oxalate transporter SLC26A6. | 2016 Dec 1 |
11 |
| 9 |
23596171 | Extracellular nucleotides inhibit oxalate transport by human intestinal Caco-2-BBe cells through PKC-δ activation. | 2013 Jul 1 |
5 |
| 10 |
21956166 | Cholinergic signaling inhibits oxalate transport by human intestinal T84 cells. | 2012 Jan 1 |
4 |
| 11 |
22494765 | Re: net intestinal transport of oxalate reflects passive absorption and SLC26A6-mediated secretion. | 2012 May |
1 |
| 12 |
21170874 | Role of SLC26A6-mediated Cl⁻-oxalate exchange in renal physiology and pathophysiology. | 2010 Nov-Dec |
1 |
| 13 |
19029225 | Analysis of the 206M polymorphic variant of the SLC26A6 gene encoding a Cl- oxalate transporter in patients with primary hyperparathyroidism. | 2009 Feb |
1 |
| 14 |
20501439 | Parsing apical oxalate exchange in Caco-2BBe1 monolayers: siRNA knockdown of SLC26A6 reveals the role and properties of PAT-1. | 2009 Nov |
1 |
| 15 |
18174209 | Species differences in Cl- affinity and in electrogenicity of SLC26A6-mediated oxalate/Cl- exchange correlate with the distinct human and mouse susceptibilities to nephrolithiasis. | 2008 Mar 1 |
6 |
| 16 |
18310129 | The role of SLC26A6-mediated chloride/oxalate exchange in causing susceptibility to nephrolithiasis. | 2008 Mar 1 |
1 |
| 17 |
18523430 | Oxalate in renal stone disease: the terminal metabolite that just won't go away. | 2008 Jul |
2 |
| 18 |
15548529 | Functional comparison of mouse slc26a6 anion exchanger with human SLC26A6 polypeptide variants: differences in anion selectivity, regulation, and electrogenicity. | 2005 Mar 4 |
3 |
| 19 |
15956810 | SLC26A6 and SLC26A7 anion exchangers have a distinct distribution in human kidney. | 2005 |
1 |
| 20 |
15203903 | Role of anion exchange transporter PAT1 (SLC26A6) in intestinal absorption of organic anions. | 2004 Feb |
2 |